Jerash Holdings (US) - JRSH Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Jerash Holdings (US) in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" JRSH shares.
View JRSH analyst ratings or view top-rated stocks.

3 equities research analysts have issued 12-month price targets for Jerash Holdings (US)'s shares. Their JRSH share price forecasts range from $10.00 to $11.00. On average, they anticipate the company's stock price to reach $10.50 in the next year. This suggests a possible upside of 98.9% from the stock's current price.
View analysts price targets for JRSH or view top-rated stocks among Wall Street analysts.

Jerash Holdings (US)'s stock was trading at $6.47 at the start of the year. Since then, JRSH stock has decreased by 18.4% and is now trading at $5.28.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our JRSH earnings forecast.

Jerash Holdings (US), Inc. (NASDAQ:JRSH) issued its quarterly earnings data on Thursday, June, 23rd. The company reported ($0.01) EPS for the quarter. The business earned $30.94 million during the quarter. Jerash Holdings (US) had a net margin of 5.25% and a trailing twelve-month return on equity of 11.32%. During the same period last year, the company earned $0.06 EPS.

Jerash Holdings (US) declared a quarterly dividend on Friday, August 5th. Stockholders of record on Wednesday, August 17th will be given a dividend of $0.05 per share on Wednesday, August 24th. This represents a $0.20 annualized dividend and a dividend yield of 3.79%. The ex-dividend date of this dividend is Tuesday, August 16th.
Read our dividend analysis for JRSH.

Jerash Holdings (US) (NASDAQ:JRSH) pays an annual dividend of $0.20 per share and currently has a dividend yield of 3.77%. The dividend payout ratio is 30.77%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for JRSH.

Jerash Holdings (US) issued an update on its second quarter 2023 earnings guidance on Friday, August, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $41.00 million-$43.00 million, compared to the consensus revenue estimate of $45.05 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Jerash Holdings (US) investors own include Pfizer (PFE), AbbVie (ABBV), Ampio Pharmaceuticals (AMPE), Applied DNA Sciences (APDN), Brainstorm Cell Therapeutics (BCLI), Bionano Genomics (BNGO), ChromaDex (CDXC), Chimerix (CMRX) and Cinemark (CNK).

Jerash Holdings (US) trades on the NASDAQ under the ticker symbol "JRSH."

Jerash Holdings (US)'s stock is owned by a variety of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.96%).
View institutional ownership trends.

Shares of JRSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of JRSH stock can currently be purchased for approximately $5.28.

Jerash Holdings (US) (NASDAQ:JRSH) has a market capitalization of $66.16 million and generates $143.35 million in revenue each year. The company earns $7.92 million in net income (profit) each year or $0.65 on an earnings per share basis.

The company employs 5,600 workers across the globe.

Jerash Holdings (US)'s mailing address is 260 EAST MAIN STREET SUITE 2706, ROCHESTER NY, 14604. The official website for the company is www.jerashholdings.com. The company can be reached via phone at (214) 906-0065 or via email at mkreps@darrowir.com.